Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03459456 · ClinicalTrials.gov registry record
Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)
A clinical trial of Obsessive - Compulsive Disorder and OCD, sponsored by Baylor College of Medicine.
- Active
- Registry status
- 27
- Enrollment target
- 3
- Study locations
NCT03459456: Active study of Obsessive - Compulsive Disorder and OCD, sponsored by Baylor College of Medicine.
NCT03459456 is a study of Obsessive - Compulsive Disorder and OCD that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 27 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03459456, a study of Obsessive - Compulsive Disorder and OCD, is active but no longer recruiting, sponsored by Baylor College of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- 27 participants
- Enrollment target
- 3
- Study locations
Study Summary
The investigators propose to synchronize automated measurements of behavior - head, body, and face dynamics, gaze, and vocal prosody - with simultaneous recordings of brain activity in clinically relevant contexts.
Primary Outcome
measured before, during and after PROVOC task, Trier Social Stress Test (TSST) and exposure task
Conditions Studied
Interventions
- BEHAVIORAL Trier Social Stress Test (TSST)
- BEHAVIORAL Provocation OC task (Provoc)
- BEHAVIORAL Exposure provocation task
Study Locations (3)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Rhode Island
- Brown University - Providence
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-06-11 |
| Est. Completion | 2026-07 |
What the registry record for NCT03459456 still lists
NCT03459456 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 3 interventions - of which Trier Social Stress Test (TSST) is the first listed.
NCT03459456 reports a single indexed study location in Pennsylvania, Rhode Island, Texas.
Frequently Asked Questions
What is clinical trial NCT03459456 about?
NCT03459456 is a clinical study titled "Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)". The investigators propose to synchronize automated measurements of behavior - head, body, and face dynamics, gaze, and vocal prosody - with simultaneous recordings of brain activity in clinically relevant contexts.
What is the current status of trial NCT03459456?
This trial is currently active not recruiting. The enrollment target is 27 participants. The study started on 2018-06-11. Estimated completion is 2026-07.
What conditions does trial NCT03459456 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder, OCD.
What interventions are being tested in trial NCT03459456?
The interventions under investigation include: Trier Social Stress Test (TSST) (BEHAVIORAL), Provocation OC task (Provoc) (BEHAVIORAL), Exposure provocation task (BEHAVIORAL).
Who is sponsoring clinical trial NCT03459456?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03459456 being conducted?
This trial has 3 study locations across Pennsylvania, Rhode Island, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03459456's enrollment target sits among peer trials
27 65th of 84 higher than 18 of 84 other Obsessive - Compulsive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
RECRUITING · Phase 1
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI